Syphilis Spreads at San Diego-Tijuana Border Amid Drug Shortage and Research Constraints

Syphilis cases are rising significantly at the San Diego-Tijuana border, where researchers face mounting challenges including federal restrictions and critical shortages of treatment medications. The combination of limited access to drugs like penicillin and regulatory barriers is hampering disease control efforts in this high-risk region. Public health officials warn that untreated syphilis can lead to serious complications including neurological damage and organ involvement. The shortage highlights vulnerabilities in pharmaceutical supply chains and the need for coordinated border health policies to combat this preventable infection.